Gamma Knife Market
Gamma Knife Market is segmented by Disease Indication (Brain Metastasis, Cancer, Arteriovenous Malformation, Trigeminal Neuralgia, Others), Anatomy (Head, Neck, Other Body Parts), End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers), and Region. Forecast for 2026 to 2036.
Gamma Knife Market Size, Market Forecast and Outlook By FMI
Summary of the Gamma Knife Market
- Demand and Growth Drivers
- Rising incidence of brain metastases from primary cancers including lung, breast, and melanoma is sustaining demand for Gamma Knife radiosurgery as a precision treatment alternative to whole brain radiation therapy.
- Growing preference for single session, non-invasive treatment of intracranial lesions is shifting oncology referral patterns toward Gamma Knife centers that offer stereotactic radiosurgery with minimal recovery time.
- Expanding clinical indications beyond oncology into functional neurosurgery for trigeminal neuralgia, essential tremor, and arteriovenous malformations are broadening the patient base for Gamma Knife treatment.
- Product and Segment View
- Brain Metastasis accounts for 69.5% of the disease indication segment in 2026, driven by rising metastatic cancer incidence and growing preference for targeted radiosurgery over whole brain radiation.
- Head holds 54.3% of the anatomy segment, reflecting the concentration of Gamma Knife applications in intracranial lesion treatment.
- Hospitals remain the primary end use setting for Gamma Knife installations, given the capital equipment requirements and multidisciplinary team infrastructure needed for radiosurgery programs.
- Geography and Competitive Outlook
- The USA and South Korea are each expected to register CAGRs of 7.4% through 2036, driven by oncology infrastructure, brain metastasis treatment demand, and radiosurgery center expansion.
- Japan at 7.3% reflects advanced neurosurgical capabilities, high cancer incidence, and established Gamma Knife treatment infrastructure.
- Elekta leads through its dominant position in Gamma Knife technology with the Leksell Gamma Knife platform as the global standard for cranial stereotactic radiosurgery.
- Analyst Opinion
- 'Gamma Knife radiosurgery is becoming an increasingly central component of brain tumor treatment algorithms. The demonstrated precision, single session delivery, and expanding clinical indications position Gamma Knife as a growth category within the broader radiation oncology market,' says Sabyasachi Ghosh, Managing Director at FMI.
- The market is expanding as clinical evidence supports Gamma Knife treatment for an increasing number of intracranial conditions beyond traditional oncology applications.
- Adoption is increasing as oncology treatment guidelines shift toward stereotactic radiosurgery for brain metastases management, particularly for patients with limited numbers of metastatic lesions.
- Demand is further shaped by the procedural efficiency of single session Gamma Knife treatment compared to fractionated radiation therapy, which reduces treatment burden and healthcare resource utilization.
Gamma Knife Market Definition
The Gamma Knife Market covers stereotactic radiosurgery systems, components, and services used for non-invasive treatment of intracranial conditions including brain metastases, primary brain tumors, arteriovenous malformations, trigeminal neuralgia, and other functional neurological disorders using focused gamma radiation beams.
Gamma Knife Market Inclusions
Market scope includes all commercially traded Gamma Knife systems and related products classified by disease indication (brain metastasis, cancer, arteriovenous malformation, trigeminal neuralgia), anatomy (head, neck, other body parts), end user (hospitals, specialty clinics, ambulatory surgical centers), and application (oncology, neurology, vascular disorders). Revenue coverage spans 2026 to 2036.
Gamma Knife Market Exclusions
The scope does not include linear accelerator based stereotactic radiosurgery systems (CyberKnife, LINAC based SRS), proton therapy systems, or conventional external beam radiation therapy equipment.
Gamma Knife Market Research Methodology
- Primary Research: FMI analysts conducted interviews with industry participants, technology providers, and end users across key markets.
- Desk Research: Combined data from industry associations, regulatory filings, and manufacturer disclosures.
- Market Sizing and Forecasting: Bottom up aggregation across segments and regions with top down validation.
- Data Validation: Cross checked quarterly against industry data and manufacturer disclosures.
Why is the Gamma Knife Market Growing?
- Brain metastasis treatment volume growth is sustained by rising cancer incidence and survival improvements that increase the lifetime risk of brain metastases, creating a growing patient population requiring intracranial treatment.
- Non-invasive treatment preference is shifting referral patterns from surgical resection toward Gamma Knife radiosurgery for eligible brain lesions, supported by clinical outcomes data demonstrating comparable local control rates.
Demand for Gamma Knife radiosurgery reflects the intersection of rising brain metastasis incidence and the clinical advantages of precision non-invasive treatment. Brain metastases occur in approximately 20 to 40% of cancer patients, with incidence increasing as systemic therapies improve overall survival and enable longer disease trajectories during which brain involvement may develop. Gamma Knife delivers highly focused radiation to intracranial targets with sub-millimeter precision, treating lesions in a single session while minimizing radiation exposure to surrounding healthy brain tissue.
The clinical evidence supporting Gamma Knife for brain metastasis management has strengthened considerably, with randomized trials demonstrating comparable survival outcomes to whole brain radiation therapy with significantly reduced neurocognitive toxicity. This evidence has shifted oncology treatment algorithms toward stereotactic radiosurgery for patients with limited numbers of brain metastases, expanding the addressable patient population for Gamma Knife treatment.
Functional neurosurgery applications represent a growing diversification of the Gamma Knife addressable market. Treatment of trigeminal neuralgia, essential tremor, and obsessive compulsive disorder using Gamma Knife radiosurgery is gaining clinical acceptance, supported by outcomes data demonstrating symptom relief without surgical craniotomy. These non-oncology applications expand the clinical utilization of existing Gamma Knife installations and support the economic case for new system procurement.
Market Segmentation Analysis
- Brain Metastasis accounts for 69.5% of the disease indication segment, reflecting the dominant clinical application of Gamma Knife technology in managing intracranial metastatic disease.
- Head holds 54.3% of the anatomy segment, driven by the concentration of Gamma Knife treatment in intracranial targets.
The Gamma Knife Market is segmented by disease indication, anatomy, end user, and application. Brain Metastasis dominates the disease indication segment. Head leads the anatomy segment as the primary anatomical target for Gamma Knife radiosurgery.
Insights into the Brain Metastasis Disease Indication Segment
In 2026, Brain Metastasis is expected to represent 69.5% of the disease indication segment. This category covers Gamma Knife treatment of intracranial metastases from primary cancers including lung, breast, melanoma, renal, and colorectal origins. Treatment volumes are concentrated in comprehensive cancer centers and dedicated radiosurgery programs.
Growth reflects rising brain metastasis incidence driven by improved systemic therapy outcomes that extend survival and increase cumulative brain metastasis risk.
Insights into the Head Anatomy Segment
Head accounts for 54.3% of the anatomy segment in 2026. Gamma Knife technology is specifically designed for intracranial applications, using a fixed frame or mask based immobilization system to deliver focused radiation to brain targets with sub-millimeter accuracy.
Growth reflects the expanding scope of intracranial conditions treated by Gamma Knife, including brain metastases, acoustic neuromas, meningiomas, trigeminal neuralgia, and emerging functional neurosurgery applications.
Gamma Knife Market Drivers, Restraints, and Opportunities
- Brain metastasis incidence growth and non-invasive treatment preference sustain demand for Gamma Knife radiosurgery.
- High system acquisition costs and facility requirements limit installation growth to large hospitals and dedicated radiosurgery centers.
- Expanding clinical indications beyond oncology into functional neurosurgery are broadening the patient base and improving system utilization economics.
The Gamma Knife Market is shaped by cancer incidence trends, non-invasive treatment preference, and clinical indication expansion. Growth is supported by brain metastasis treatment demand, while barriers include high system costs.
Brain Metastasis Incidence Growth
Demand is shaped by rising brain metastasis incidence driven by improved systemic cancer treatments that extend patient survival. Longer survival increases the lifetime probability of brain metastasis development, expanding the treatable patient population.
System Cost and Facility Barriers
Growth is moderated by the high acquisition cost of Gamma Knife systems (typically USD 4 to 6 million) and the facility requirements including radiation shielded vaults. These barriers limit new installations to large hospitals and academic medical centers.
Clinical Indication Expansion
Adoption benefits from expanding clinical indications including trigeminal neuralgia, essential tremor, and arteriovenous malformation treatment that broaden the patient base beyond oncology and improve system utilization economics.
Analysis of Gamma Knife Market By Key Countries
.webp "Top Country Growth Comparison Gamma Knife Market Cagr (2026 2036)")
| Country | CAGR |
|---|---|
| USA | 7.4% |
| South Korea | 7.4% |
| Japan | 7.3% |
| European Union | 7.1% |
| UK | 7% |
- The USA and South Korea lead with 7.4% CAGRs through 2036, driven by oncology infrastructure, brain metastasis treatment demand, and radiosurgery program expansion.
- Japan at 7.3% reflects advanced neurosurgical capabilities and high installed base of Gamma Knife systems.
- The EU (7.1%) and UK (7.0%) show growth driven by comprehensive cancer center expansion and clinical evidence based adoption.
The global Gamma Knife Market is projected to grow at a CAGR of 7.6% from 2026 to 2036. The analysis covers more than 30 countries.
Demand Outlook for Gamma Knife Market in the United States
The USA is expected to grow at 7.4% through 2036, anchored in brain metastasis treatment demand, comprehensive cancer center infrastructure, and expanding radiosurgery indications.
- Brain metastasis treatment volume growth sustains Gamma Knife procedure demand.
- Comprehensive cancer centers provide infrastructure for radiosurgery program expansion.
- Functional neurosurgery applications broaden clinical utilization beyond oncology.
Future Outlook for Gamma Knife Market in South Korea
South Korea is expected to grow at 7.4% through 2036, reflecting oncology infrastructure investment and growing radiosurgery adoption.
- Oncology infrastructure investment supports Gamma Knife installation and program expansion.
- Brain metastasis treatment demand drives procedure volume growth.
- Advanced medical technology adoption supports early uptake of radiosurgery capabilities.
Opportunity Analysis of Gamma Knife Market in Japan
Japan is expected to grow at 7.3% through 2036, driven by advanced neurosurgical capabilities and high installed base.
- High installed base sustains procedure volumes and upgrade demand.
- Advanced neurosurgical capabilities support complex radiosurgery applications.
- Aging population cancer incidence drives brain metastasis treatment demand.
In-depth Analysis of Gamma Knife Market in the European Union
The European Union is expected to grow at 7.1% through 2036, reflecting comprehensive cancer center expansion and evidence based treatment adoption.
- Comprehensive cancer center expansion supports Gamma Knife program development.
- Clinical evidence based guidelines drive adoption of radiosurgery for brain metastases.
- Academic medical centers support functional neurosurgery application development.
Sales Analysis of Gamma Knife Market in the United Kingdom
The UK is expected to grow at 7.0% through 2036, supported by NHS cancer treatment modernization and radiosurgery program expansion.
- NHS cancer treatment modernization supports radiosurgery infrastructure investment.
- Brain metastasis treatment demand drives Gamma Knife procedure growth.
- NICE technology appraisals support evidence based adoption of radiosurgery.
Competitive Landscape and Strategic Positioning
- Elekta leads through its dominant position as the sole manufacturer of the Leksell Gamma Knife platform, the global standard for cranial stereotactic radiosurgery.
- Varian Medical Systems and Accuray provide competing stereotactic radiosurgery platforms based on linear accelerator technology that address overlapping clinical indications.
- Emerging players in complementary markets provide treatment planning software, patient positioning systems, and quality assurance solutions for Gamma Knife programs.
Elekta maintains a dominant position as the developer and sole manufacturer of the Leksell Gamma Knife platform, the established global standard for cranial stereotactic radiosurgery. The Gamma Knife system uses focused cobalt-60 gamma radiation beams for sub-millimeter precision treatment of intracranial targets.
Varian Medical Systems provides LINAC based stereotactic radiosurgery capabilities that compete for overlapping clinical indications. Accuray offers the CyberKnife robotic radiosurgery system that addresses both cranial and extracranial targets.
Barriers to entry include the specialized physics and engineering expertise required for radiosurgery system development, regulatory approval complexity, the high capital cost of systems limiting the buyer universe, and Elekta's established clinical evidence base and installed user community. Strategic priorities include expanding clinical indications, improving treatment planning efficiency, and developing next generation system capabilities.
Key Companies in the Gamma Knife Market
Key global companies leading the gamma knife market include:
- Elekta, Varian Medical Systems, Accuray Incorporated maintain leadership through established market presence and product portfolios.
- Hitachi, Ltd. have established positions through specialized capabilities.
- Huiheng Medical, Inc., Akesis, Inc., MASEP Medical Science Technology, American Radiosurgery Inc. are among the emerging players gaining traction.
Competitive Benchmarking: Gamma Knife Market
| Company | Radiosurgery Technology | Clinical Evidence | Treatment Planning | Geographic Coverage |
|---|---|---|---|---|
| Elekta | High | Extensive | High | Global |
| Varian Medical Systems | High | Strong | High | Global |
| Accuray | Medium | Moderate | Medium | Global |
| Huiheng Medical | Low | Limited | Low | China |
| Panacea Medical Tech | Low | Limited | Low | India |
Source: Future Market Insights competitive analysis, 2026.
Key Players in the Gamma Knife Market
Major Global Players
- Elekta
- Varian Medical Systems
- Accuray Incorporated
- Hitachi, Ltd.
Emerging Players/Startups
- Huiheng Medical, Inc.
- Akesis, Inc.
- MASEP Medical Science Technology
- American Radiosurgery Inc.
- Panacea Medical Technologies
- Nordion (Canada) Inc.
Report Scope and Coverage
| Metric | Value |
|---|---|
| Quantitative Units | USD 420.61 million to USD 874.99 million, at a CAGR of 7.6% |
| Market Definition | The Gamma Knife Market covers stereotactic radiosurgery systems for non-invasive treatment of intracranial conditions using focused gamma radiation. |
| Regions Covered | North America, Latin America, Europe, East Asia, South Asia and Pacific, Middle East and Africa |
| Countries Covered | USA, UK, Germany, South Korea, Japan, China, India, France, 30 plus countries |
| Key Companies Profiled | Elekta, Varian Medical Systems, Accuray, Huiheng Medical, Akesis, MASEP Medical, American Radiosurgery, Panacea Medical Technologies, Nordion, Hitachi |
| Forecast Period | 2026 to 2036 |
| Approach | Hybrid bottom up and top down methodology starting with verified transaction data, projecting adoption velocity across segments and regions. |
Segmentation
Gamma Knife Market Segmented by Disease Indication:
- Brain Metastasis
- Cancer
- Arteriovenous Malformation
- Trigeminal Neuralgia
- Others
Gamma Knife Market Segmented by Anatomy:
- Head
- Neck
- Other Body Parts
Gamma Knife Market Segmented by End User:
- Hospitals
- Specialty Clinics
- Ambulatory Surgical Centers
Gamma Knife Market Segmented by Application:
- Oncology
- Neurology
- Vascular Disorders
Gamma Knife Market by Region:
- North America
- USA
- Canada
- Mexico
- Latin America
- Brazil
- Chile
- Rest of Latin America
- Western Europe
- Germany
- UK
- Italy
- Spain
- France
- Nordic
- BENELUX
- Rest of Western Europe
- Eastern Europe
- Russia
- Poland
- Hungary
- Balkan & Baltic
- Rest of Eastern Europe
- East Asia
- China
- Japan
- South Korea
- South Asia and Pacific
- India
- ASEAN
- Australia & New Zealand
- Rest of South Asia and Pacific
- Middle East & Africa
- Kingdom of Saudi Arabia
- Other GCC Countries
- Turkiye
- South Africa
- Other African Union
- Rest of Middle East & Africa
Research Sources and Bibliography
1. American Society for Radiation Oncology. (2025). ASTRO Clinical Practice Guidelines: Stereotactic Radiosurgery for Brain Metastases. ASTRO.
2. International Stereotactic Radiosurgery Society. (2025). ISRS Practice Guidelines for Gamma Knife Radiosurgery. ISRS.
3. World Health Organization. (2025). WHO Global Cancer Statistics and Brain Tumor Incidence Report. WHO.
4. USA Food and Drug Administration. (2025). FDA Premarket Approval: Gamma Knife Stereotactic Radiosurgery Systems. FDA.
5. European Society for Radiotherapy and Oncology. (2025). ESTRO Consensus Guidelines for Cranial Stereotactic Radiosurgery. ESTRO.
This bibliography is provided for reader reference. The full Future Market Insights report contains the complete reference list with publication dates, URLs, and supporting data for all cited works.
This Report Answers
- Estimating market size and revenue projections from 2026 to 2036.
- Segmentation by disease indication, anatomy, end user, and application.
- Regional insights covering more than 30 markets.
- Analysis of radiosurgery technology and clinical applications.
- Competitive landscape assessment.
- Growth opportunity identification in brain metastasis treatment, functional neurosurgery, and system upgrades.
- Supply chain evaluation.
- Data delivery in PDF and Excel formats.
Frequently Asked Questions
What is the global market demand for Gamma Knife in 2026?
In 2026, the global market is expected to be worth USD 420.61 million.
How big will the market be in 2036?
By 2036, the market is expected to be worth USD 874.99 million.
How much is demand expected to grow?
Between 2026 and 2036, demand is expected to grow at a CAGR of 7.6%.
Which disease indication leads in 2026?
Brain Metastasis accounts for 69.5% of the disease indication segment, driven by rising metastatic cancer incidence.
What drives demand in the USA?
The USA at 7.4% reflects brain metastasis treatment demand and comprehensive cancer center infrastructure.
What drives demand in South Korea?
South Korea at 7.4% reflects oncology investment and growing radiosurgery adoption.
What is the market definition?
The market covers stereotactic radiosurgery systems for non-invasive intracranial treatment using focused gamma radiation.
How is the forecast validated?
Hybrid bottom up and top down approach using verified system installation and procedure data validated against oncology statistics.
Table of Content
- Executive Summary
- Global Market Outlook
- Demand to side Trends
- Supply to side Trends
- Technology Roadmap Analysis
- Analysis and Recommendations
- Market Overview
- Market Coverage / Taxonomy
- Market Definition / Scope / Limitations
- Research Methodology
- Chapter Orientation
- Analytical Lens and Working Hypotheses
- Market Structure, Signals, and Trend Drivers
- Benchmarking and Cross-market Comparability
- Market Sizing, Forecasting, and Opportunity Mapping
- Research Design and Evidence Framework
- Desk Research Programme (Secondary Evidence)
- Company Annual and Sustainability Reports
- Peer-reviewed Journals and Academic Literature
- Corporate Websites, Product Literature, and Technical Notes
- Earnings Decks and Investor Briefings
- Statutory Filings and Regulatory Disclosures
- Technical White Papers and Standards Notes
- Trade Journals, Industry Magazines, and Analyst Briefs
- Conference Proceedings, Webinars, and Seminar Materials
- Government Statistics Portals and Public Data Releases
- Press Releases and Reputable Media Coverage
- Specialist Newsletters and Curated Briefings
- Sector Databases and Reference Repositories
- FMI Internal Proprietary Databases and Historical Market Datasets
- Subscription Datasets and Paid Sources
- Social Channels, Communities, and Digital Listening Inputs
- Additional Desk Sources
- Expert Input and Fieldwork (Primary Evidence)
- Primary Modes
- Qualitative Interviews and Expert Elicitation
- Quantitative Surveys and Structured Data Capture
- Blended Approach
- Why Primary Evidence is Used
- Field Techniques
- Interviews
- Surveys
- Focus Groups
- Observational and In-context Research
- Social and Community Interactions
- Stakeholder Universe Engaged
- C-suite Leaders
- Board Members
- Presidents and Vice Presidents
- R&D and Innovation Heads
- Technical Specialists
- Domain Subject-matter Experts
- Scientists
- Physicians and Other Healthcare Professionals
- Governance, Ethics, and Data Stewardship
- Research Ethics
- Data Integrity and Handling
- Primary Modes
- Tooling, Models, and Reference Databases
- Desk Research Programme (Secondary Evidence)
- Data Engineering and Model Build
- Data Acquisition and Ingestion
- Cleaning, Normalisation, and Verification
- Synthesis, Triangulation, and Analysis
- Quality Assurance and Audit Trail
- Market Background
- Market Dynamics
- Drivers
- Restraints
- Opportunity
- Trends
- Scenario Forecast
- Demand in Optimistic Scenario
- Demand in Likely Scenario
- Demand in Conservative Scenario
- Opportunity Map Analysis
- Product Life Cycle Analysis
- Supply Chain Analysis
- Investment Feasibility Matrix
- Value Chain Analysis
- PESTLE and Porter’s Analysis
- Regulatory Landscape
- Regional Parent Market Outlook
- Production and Consumption Statistics
- Import and Export Statistics
- Market Dynamics
- Global Market Analysis 2021 to 2025 and Forecast, 2026 to 2036
- Historical Market Size Value (USD Million) Analysis, 2021 to 2025
- Current and Future Market Size Value (USD Million) Projections, 2026 to 2036
- Y to o to Y Growth Trend Analysis
- Absolute $ Opportunity Analysis
- Global Market Pricing Analysis 2021 to 2025 and Forecast 2026 to 2036
- Global Market Analysis 2021 to 2025 and Forecast 2026 to 2036, By Disease Indication
- Introduction / Key Findings
- Historical Market Size Value (USD Million) Analysis By Disease Indication, 2021 to 2025
- Current and Future Market Size Value (USD Million) Analysis and Forecast By Disease Indication, 2026 to 2036
- Brain Metastasis
- Cancer
- Arteriovenous Malformation
- Trigeminal Neuralgia
- Others
- Brain Metastasis
- Y to o to Y Growth Trend Analysis By Disease Indication, 2021 to 2025
- Absolute $ Opportunity Analysis By Disease Indication, 2026 to 2036
- Global Market Analysis 2021 to 2025 and Forecast 2026 to 2036, By Anatomy
- Introduction / Key Findings
- Historical Market Size Value (USD Million) Analysis By Anatomy, 2021 to 2025
- Current and Future Market Size Value (USD Million) Analysis and Forecast By Anatomy, 2026 to 2036
- Head
- Neck
- Other Body Parts
- Head
- Y to o to Y Growth Trend Analysis By Anatomy, 2021 to 2025
- Absolute $ Opportunity Analysis By Anatomy, 2026 to 2036
- Global Market Analysis 2021 to 2025 and Forecast 2026 to 2036, By End User
- Introduction / Key Findings
- Historical Market Size Value (USD Million) Analysis By End User, 2021 to 2025
- Current and Future Market Size Value (USD Million) Analysis and Forecast By End User, 2026 to 2036
- Hospitals
- Specialty Clinics
- Ambulatory Surgical Centers
- Hospitals
- Y to o to Y Growth Trend Analysis By End User, 2021 to 2025
- Absolute $ Opportunity Analysis By End User, 2026 to 2036
- Global Market Analysis 2021 to 2025 and Forecast 2026 to 2036, By Application
- Introduction / Key Findings
- Historical Market Size Value (USD Million) Analysis By Application, 2021 to 2025
- Current and Future Market Size Value (USD Million) Analysis and Forecast By Application, 2026 to 2036
- Oncology
- Neurology
- Vascular Disorders
- Oncology
- Y to o to Y Growth Trend Analysis By Application, 2021 to 2025
- Absolute $ Opportunity Analysis By Application, 2026 to 2036
- Global Market Analysis 2021 to 2025 and Forecast 2026 to 2036, By Region
- Introduction
- Historical Market Size Value (USD Million) Analysis By Region, 2021 to 2025
- Current Market Size Value (USD Million) Analysis and Forecast By Region, 2026 to 2036
- North America
- Latin America
- Western Europe
- Eastern Europe
- East Asia
- South Asia and Pacific
- Middle East & Africa
- Market Attractiveness Analysis By Region
- North America Market Analysis 2021 to 2025 and Forecast 2026 to 2036, By Country
- Historical Market Size Value (USD Million) Trend Analysis By Market Taxonomy, 2021 to 2025
- Market Size Value (USD Million) Forecast By Market Taxonomy, 2026 to 2036
- By Country
- USA
- Canada
- Mexico
- By Disease Indication
- By Anatomy
- By End User
- By Application
- By Country
- Market Attractiveness Analysis
- By Country
- By Disease Indication
- By Anatomy
- By End User
- By Application
- Key Takeaways
- Latin America Market Analysis 2021 to 2025 and Forecast 2026 to 2036, By Country
- Historical Market Size Value (USD Million) Trend Analysis By Market Taxonomy, 2021 to 2025
- Market Size Value (USD Million) Forecast By Market Taxonomy, 2026 to 2036
- By Country
- Brazil
- Chile
- Rest of Latin America
- By Disease Indication
- By Anatomy
- By End User
- By Application
- By Country
- Market Attractiveness Analysis
- By Country
- By Disease Indication
- By Anatomy
- By End User
- By Application
- Key Takeaways
- Western Europe Market Analysis 2021 to 2025 and Forecast 2026 to 2036, By Country
- Historical Market Size Value (USD Million) Trend Analysis By Market Taxonomy, 2021 to 2025
- Market Size Value (USD Million) Forecast By Market Taxonomy, 2026 to 2036
- By Country
- Germany
- UK
- Italy
- Spain
- France
- Nordic
- BENELUX
- Rest of Western Europe
- By Disease Indication
- By Anatomy
- By End User
- By Application
- By Country
- Market Attractiveness Analysis
- By Country
- By Disease Indication
- By Anatomy
- By End User
- By Application
- Key Takeaways
- Eastern Europe Market Analysis 2021 to 2025 and Forecast 2026 to 2036, By Country
- Historical Market Size Value (USD Million) Trend Analysis By Market Taxonomy, 2021 to 2025
- Market Size Value (USD Million) Forecast By Market Taxonomy, 2026 to 2036
- By Country
- Russia
- Poland
- Hungary
- Balkan & Baltic
- Rest of Eastern Europe
- By Disease Indication
- By Anatomy
- By End User
- By Application
- By Country
- Market Attractiveness Analysis
- By Country
- By Disease Indication
- By Anatomy
- By End User
- By Application
- Key Takeaways
- East Asia Market Analysis 2021 to 2025 and Forecast 2026 to 2036, By Country
- Historical Market Size Value (USD Million) Trend Analysis By Market Taxonomy, 2021 to 2025
- Market Size Value (USD Million) Forecast By Market Taxonomy, 2026 to 2036
- By Country
- China
- Japan
- South Korea
- By Disease Indication
- By Anatomy
- By End User
- By Application
- By Country
- Market Attractiveness Analysis
- By Country
- By Disease Indication
- By Anatomy
- By End User
- By Application
- Key Takeaways
- South Asia and Pacific Market Analysis 2021 to 2025 and Forecast 2026 to 2036, By Country
- Historical Market Size Value (USD Million) Trend Analysis By Market Taxonomy, 2021 to 2025
- Market Size Value (USD Million) Forecast By Market Taxonomy, 2026 to 2036
- By Country
- India
- ASEAN
- Australia & New Zealand
- Rest of South Asia and Pacific
- By Disease Indication
- By Anatomy
- By End User
- By Application
- By Country
- Market Attractiveness Analysis
- By Country
- By Disease Indication
- By Anatomy
- By End User
- By Application
- Key Takeaways
- Middle East & Africa Market Analysis 2021 to 2025 and Forecast 2026 to 2036, By Country
- Historical Market Size Value (USD Million) Trend Analysis By Market Taxonomy, 2021 to 2025
- Market Size Value (USD Million) Forecast By Market Taxonomy, 2026 to 2036
- By Country
- Kingdom of Saudi Arabia
- Other GCC Countries
- Turkiye
- South Africa
- Other African Union
- Rest of Middle East & Africa
- By Disease Indication
- By Anatomy
- By End User
- By Application
- By Country
- Market Attractiveness Analysis
- By Country
- By Disease Indication
- By Anatomy
- By End User
- By Application
- Key Takeaways
- Key Countries Market Analysis
- USA
- Pricing Analysis
- Market Share Analysis, 2025
- By Disease Indication
- By Anatomy
- By End User
- By Application
- Canada
- Pricing Analysis
- Market Share Analysis, 2025
- By Disease Indication
- By Anatomy
- By End User
- By Application
- Mexico
- Pricing Analysis
- Market Share Analysis, 2025
- By Disease Indication
- By Anatomy
- By End User
- By Application
- Brazil
- Pricing Analysis
- Market Share Analysis, 2025
- By Disease Indication
- By Anatomy
- By End User
- By Application
- Chile
- Pricing Analysis
- Market Share Analysis, 2025
- By Disease Indication
- By Anatomy
- By End User
- By Application
- Germany
- Pricing Analysis
- Market Share Analysis, 2025
- By Disease Indication
- By Anatomy
- By End User
- By Application
- UK
- Pricing Analysis
- Market Share Analysis, 2025
- By Disease Indication
- By Anatomy
- By End User
- By Application
- Italy
- Pricing Analysis
- Market Share Analysis, 2025
- By Disease Indication
- By Anatomy
- By End User
- By Application
- Spain
- Pricing Analysis
- Market Share Analysis, 2025
- By Disease Indication
- By Anatomy
- By End User
- By Application
- France
- Pricing Analysis
- Market Share Analysis, 2025
- By Disease Indication
- By Anatomy
- By End User
- By Application
- India
- Pricing Analysis
- Market Share Analysis, 2025
- By Disease Indication
- By Anatomy
- By End User
- By Application
- ASEAN
- Pricing Analysis
- Market Share Analysis, 2025
- By Disease Indication
- By Anatomy
- By End User
- By Application
- Australia & New Zealand
- Pricing Analysis
- Market Share Analysis, 2025
- By Disease Indication
- By Anatomy
- By End User
- By Application
- China
- Pricing Analysis
- Market Share Analysis, 2025
- By Disease Indication
- By Anatomy
- By End User
- By Application
- Japan
- Pricing Analysis
- Market Share Analysis, 2025
- By Disease Indication
- By Anatomy
- By End User
- By Application
- South Korea
- Pricing Analysis
- Market Share Analysis, 2025
- By Disease Indication
- By Anatomy
- By End User
- By Application
- Russia
- Pricing Analysis
- Market Share Analysis, 2025
- By Disease Indication
- By Anatomy
- By End User
- By Application
- Poland
- Pricing Analysis
- Market Share Analysis, 2025
- By Disease Indication
- By Anatomy
- By End User
- By Application
- Hungary
- Pricing Analysis
- Market Share Analysis, 2025
- By Disease Indication
- By Anatomy
- By End User
- By Application
- Kingdom of Saudi Arabia
- Pricing Analysis
- Market Share Analysis, 2025
- By Disease Indication
- By Anatomy
- By End User
- By Application
- Turkiye
- Pricing Analysis
- Market Share Analysis, 2025
- By Disease Indication
- By Anatomy
- By End User
- By Application
- South Africa
- Pricing Analysis
- Market Share Analysis, 2025
- By Disease Indication
- By Anatomy
- By End User
- By Application
- USA
- Market Structure Analysis
- Competition Dashboard
- Competition Benchmarking
- Market Share Analysis of Top Players
- By Regional
- By Disease Indication
- By Anatomy
- By End User
- By Application
- Competition Analysis
- Competition Deep Dive
- Elekta
- Overview
- Product Portfolio
- Profitability by Market Segments (Product/Age /Sales Channel/Region)
- Sales Footprint
- Strategy Overview
- Marketing Strategy
- Product Strategy
- Channel Strategy
- Varian Medical Systems
- Huiheng Medical, Inc.
- Akesis, Inc.
- MASEP Medical Science Technology Development Co. Ltd.
- American Radiosurgery Inc.
- Panacea Medical Technologies Pvt. Ltd.
- Nordion (Canada) Inc.
- Accuray Incorporated
- Hitachi, Ltd.
- Elekta
- Competition Deep Dive
- Assumptions & Acronyms Used
List of Tables
- Table 1: Global Market Value (USD Million) Forecast by Region, 2021 to 2036
- Table 2: Global Market Value (USD Million) Forecast by Disease Indication, 2021 to 2036
- Table 3: Global Market Value (USD Million) Forecast by Anatomy, 2021 to 2036
- Table 4: Global Market Value (USD Million) Forecast by End User, 2021 to 2036
- Table 5: Global Market Value (USD Million) Forecast by Application, 2021 to 2036
- Table 6: North America Market Value (USD Million) Forecast by Country, 2021 to 2036
- Table 7: North America Market Value (USD Million) Forecast by Disease Indication, 2021 to 2036
- Table 8: North America Market Value (USD Million) Forecast by Anatomy, 2021 to 2036
- Table 9: North America Market Value (USD Million) Forecast by End User, 2021 to 2036
- Table 10: North America Market Value (USD Million) Forecast by Application, 2021 to 2036
- Table 11: Latin America Market Value (USD Million) Forecast by Country, 2021 to 2036
- Table 12: Latin America Market Value (USD Million) Forecast by Disease Indication, 2021 to 2036
- Table 13: Latin America Market Value (USD Million) Forecast by Anatomy, 2021 to 2036
- Table 14: Latin America Market Value (USD Million) Forecast by End User, 2021 to 2036
- Table 15: Latin America Market Value (USD Million) Forecast by Application, 2021 to 2036
- Table 16: Western Europe Market Value (USD Million) Forecast by Country, 2021 to 2036
- Table 17: Western Europe Market Value (USD Million) Forecast by Disease Indication, 2021 to 2036
- Table 18: Western Europe Market Value (USD Million) Forecast by Anatomy, 2021 to 2036
- Table 19: Western Europe Market Value (USD Million) Forecast by End User, 2021 to 2036
- Table 20: Western Europe Market Value (USD Million) Forecast by Application, 2021 to 2036
- Table 21: Eastern Europe Market Value (USD Million) Forecast by Country, 2021 to 2036
- Table 22: Eastern Europe Market Value (USD Million) Forecast by Disease Indication, 2021 to 2036
- Table 23: Eastern Europe Market Value (USD Million) Forecast by Anatomy, 2021 to 2036
- Table 24: Eastern Europe Market Value (USD Million) Forecast by End User, 2021 to 2036
- Table 25: Eastern Europe Market Value (USD Million) Forecast by Application, 2021 to 2036
- Table 26: East Asia Market Value (USD Million) Forecast by Country, 2021 to 2036
- Table 27: East Asia Market Value (USD Million) Forecast by Disease Indication, 2021 to 2036
- Table 28: East Asia Market Value (USD Million) Forecast by Anatomy, 2021 to 2036
- Table 29: East Asia Market Value (USD Million) Forecast by End User, 2021 to 2036
- Table 30: East Asia Market Value (USD Million) Forecast by Application, 2021 to 2036
- Table 31: South Asia and Pacific Market Value (USD Million) Forecast by Country, 2021 to 2036
- Table 32: South Asia and Pacific Market Value (USD Million) Forecast by Disease Indication, 2021 to 2036
- Table 33: South Asia and Pacific Market Value (USD Million) Forecast by Anatomy, 2021 to 2036
- Table 34: South Asia and Pacific Market Value (USD Million) Forecast by End User, 2021 to 2036
- Table 35: South Asia and Pacific Market Value (USD Million) Forecast by Application, 2021 to 2036
- Table 36: Middle East & Africa Market Value (USD Million) Forecast by Country, 2021 to 2036
- Table 37: Middle East & Africa Market Value (USD Million) Forecast by Disease Indication, 2021 to 2036
- Table 38: Middle East & Africa Market Value (USD Million) Forecast by Anatomy, 2021 to 2036
- Table 39: Middle East & Africa Market Value (USD Million) Forecast by End User, 2021 to 2036
- Table 40: Middle East & Africa Market Value (USD Million) Forecast by Application, 2021 to 2036
List of Figures
- Figure 1: Global Market Pricing Analysis
- Figure 2: Global Market Value (USD Million) Forecast 2021-2036
- Figure 3: Global Market Value Share and BPS Analysis by Disease Indication, 2026 and 2036
- Figure 4: Global Market Y-o-Y Growth Comparison by Disease Indication, 2026-2036
- Figure 5: Global Market Attractiveness Analysis by Disease Indication
- Figure 6: Global Market Value Share and BPS Analysis by Anatomy, 2026 and 2036
- Figure 7: Global Market Y-o-Y Growth Comparison by Anatomy, 2026-2036
- Figure 8: Global Market Attractiveness Analysis by Anatomy
- Figure 9: Global Market Value Share and BPS Analysis by End User, 2026 and 2036
- Figure 10: Global Market Y-o-Y Growth Comparison by End User, 2026-2036
- Figure 11: Global Market Attractiveness Analysis by End User
- Figure 12: Global Market Value Share and BPS Analysis by Application, 2026 and 2036
- Figure 13: Global Market Y-o-Y Growth Comparison by Application, 2026-2036
- Figure 14: Global Market Attractiveness Analysis by Application
- Figure 15: Global Market Value (USD Million) Share and BPS Analysis by Region, 2026 and 2036
- Figure 16: Global Market Y-o-Y Growth Comparison by Region, 2026-2036
- Figure 17: Global Market Attractiveness Analysis by Region
- Figure 18: North America Market Incremental Dollar Opportunity, 2026-2036
- Figure 19: Latin America Market Incremental Dollar Opportunity, 2026-2036
- Figure 20: Western Europe Market Incremental Dollar Opportunity, 2026-2036
- Figure 21: Eastern Europe Market Incremental Dollar Opportunity, 2026-2036
- Figure 22: East Asia Market Incremental Dollar Opportunity, 2026-2036
- Figure 23: South Asia and Pacific Market Incremental Dollar Opportunity, 2026-2036
- Figure 24: Middle East & Africa Market Incremental Dollar Opportunity, 2026-2036
- Figure 25: North America Market Value Share and BPS Analysis by Country, 2026 and 2036
- Figure 26: North America Market Value Share and BPS Analysis by Disease Indication, 2026 and 2036
- Figure 27: North America Market Y-o-Y Growth Comparison by Disease Indication, 2026-2036
- Figure 28: North America Market Attractiveness Analysis by Disease Indication
- Figure 29: North America Market Value Share and BPS Analysis by Anatomy, 2026 and 2036
- Figure 30: North America Market Y-o-Y Growth Comparison by Anatomy, 2026-2036
- Figure 31: North America Market Attractiveness Analysis by Anatomy
- Figure 32: North America Market Value Share and BPS Analysis by End User, 2026 and 2036
- Figure 33: North America Market Y-o-Y Growth Comparison by End User, 2026-2036
- Figure 34: North America Market Attractiveness Analysis by End User
- Figure 35: North America Market Value Share and BPS Analysis by Application, 2026 and 2036
- Figure 36: North America Market Y-o-Y Growth Comparison by Application, 2026-2036
- Figure 37: North America Market Attractiveness Analysis by Application
- Figure 38: Latin America Market Value Share and BPS Analysis by Country, 2026 and 2036
- Figure 39: Latin America Market Value Share and BPS Analysis by Disease Indication, 2026 and 2036
- Figure 40: Latin America Market Y-o-Y Growth Comparison by Disease Indication, 2026-2036
- Figure 41: Latin America Market Attractiveness Analysis by Disease Indication
- Figure 42: Latin America Market Value Share and BPS Analysis by Anatomy, 2026 and 2036
- Figure 43: Latin America Market Y-o-Y Growth Comparison by Anatomy, 2026-2036
- Figure 44: Latin America Market Attractiveness Analysis by Anatomy
- Figure 45: Latin America Market Value Share and BPS Analysis by End User, 2026 and 2036
- Figure 46: Latin America Market Y-o-Y Growth Comparison by End User, 2026-2036
- Figure 47: Latin America Market Attractiveness Analysis by End User
- Figure 48: Latin America Market Value Share and BPS Analysis by Application, 2026 and 2036
- Figure 49: Latin America Market Y-o-Y Growth Comparison by Application, 2026-2036
- Figure 50: Latin America Market Attractiveness Analysis by Application
- Figure 51: Western Europe Market Value Share and BPS Analysis by Country, 2026 and 2036
- Figure 52: Western Europe Market Value Share and BPS Analysis by Disease Indication, 2026 and 2036
- Figure 53: Western Europe Market Y-o-Y Growth Comparison by Disease Indication, 2026-2036
- Figure 54: Western Europe Market Attractiveness Analysis by Disease Indication
- Figure 55: Western Europe Market Value Share and BPS Analysis by Anatomy, 2026 and 2036
- Figure 56: Western Europe Market Y-o-Y Growth Comparison by Anatomy, 2026-2036
- Figure 57: Western Europe Market Attractiveness Analysis by Anatomy
- Figure 58: Western Europe Market Value Share and BPS Analysis by End User, 2026 and 2036
- Figure 59: Western Europe Market Y-o-Y Growth Comparison by End User, 2026-2036
- Figure 60: Western Europe Market Attractiveness Analysis by End User
- Figure 61: Western Europe Market Value Share and BPS Analysis by Application, 2026 and 2036
- Figure 62: Western Europe Market Y-o-Y Growth Comparison by Application, 2026-2036
- Figure 63: Western Europe Market Attractiveness Analysis by Application
- Figure 64: Eastern Europe Market Value Share and BPS Analysis by Country, 2026 and 2036
- Figure 65: Eastern Europe Market Value Share and BPS Analysis by Disease Indication, 2026 and 2036
- Figure 66: Eastern Europe Market Y-o-Y Growth Comparison by Disease Indication, 2026-2036
- Figure 67: Eastern Europe Market Attractiveness Analysis by Disease Indication
- Figure 68: Eastern Europe Market Value Share and BPS Analysis by Anatomy, 2026 and 2036
- Figure 69: Eastern Europe Market Y-o-Y Growth Comparison by Anatomy, 2026-2036
- Figure 70: Eastern Europe Market Attractiveness Analysis by Anatomy
- Figure 71: Eastern Europe Market Value Share and BPS Analysis by End User, 2026 and 2036
- Figure 72: Eastern Europe Market Y-o-Y Growth Comparison by End User, 2026-2036
- Figure 73: Eastern Europe Market Attractiveness Analysis by End User
- Figure 74: Eastern Europe Market Value Share and BPS Analysis by Application, 2026 and 2036
- Figure 75: Eastern Europe Market Y-o-Y Growth Comparison by Application, 2026-2036
- Figure 76: Eastern Europe Market Attractiveness Analysis by Application
- Figure 77: East Asia Market Value Share and BPS Analysis by Country, 2026 and 2036
- Figure 78: East Asia Market Value Share and BPS Analysis by Disease Indication, 2026 and 2036
- Figure 79: East Asia Market Y-o-Y Growth Comparison by Disease Indication, 2026-2036
- Figure 80: East Asia Market Attractiveness Analysis by Disease Indication
- Figure 81: East Asia Market Value Share and BPS Analysis by Anatomy, 2026 and 2036
- Figure 82: East Asia Market Y-o-Y Growth Comparison by Anatomy, 2026-2036
- Figure 83: East Asia Market Attractiveness Analysis by Anatomy
- Figure 84: East Asia Market Value Share and BPS Analysis by End User, 2026 and 2036
- Figure 85: East Asia Market Y-o-Y Growth Comparison by End User, 2026-2036
- Figure 86: East Asia Market Attractiveness Analysis by End User
- Figure 87: East Asia Market Value Share and BPS Analysis by Application, 2026 and 2036
- Figure 88: East Asia Market Y-o-Y Growth Comparison by Application, 2026-2036
- Figure 89: East Asia Market Attractiveness Analysis by Application
- Figure 90: South Asia and Pacific Market Value Share and BPS Analysis by Country, 2026 and 2036
- Figure 91: South Asia and Pacific Market Value Share and BPS Analysis by Disease Indication, 2026 and 2036
- Figure 92: South Asia and Pacific Market Y-o-Y Growth Comparison by Disease Indication, 2026-2036
- Figure 93: South Asia and Pacific Market Attractiveness Analysis by Disease Indication
- Figure 94: South Asia and Pacific Market Value Share and BPS Analysis by Anatomy, 2026 and 2036
- Figure 95: South Asia and Pacific Market Y-o-Y Growth Comparison by Anatomy, 2026-2036
- Figure 96: South Asia and Pacific Market Attractiveness Analysis by Anatomy
- Figure 97: South Asia and Pacific Market Value Share and BPS Analysis by End User, 2026 and 2036
- Figure 98: South Asia and Pacific Market Y-o-Y Growth Comparison by End User, 2026-2036
- Figure 99: South Asia and Pacific Market Attractiveness Analysis by End User
- Figure 100: South Asia and Pacific Market Value Share and BPS Analysis by Application, 2026 and 2036
- Figure 101: South Asia and Pacific Market Y-o-Y Growth Comparison by Application, 2026-2036
- Figure 102: South Asia and Pacific Market Attractiveness Analysis by Application
- Figure 103: Middle East & Africa Market Value Share and BPS Analysis by Country, 2026 and 2036
- Figure 104: Middle East & Africa Market Value Share and BPS Analysis by Disease Indication, 2026 and 2036
- Figure 105: Middle East & Africa Market Y-o-Y Growth Comparison by Disease Indication, 2026-2036
- Figure 106: Middle East & Africa Market Attractiveness Analysis by Disease Indication
- Figure 107: Middle East & Africa Market Value Share and BPS Analysis by Anatomy, 2026 and 2036
- Figure 108: Middle East & Africa Market Y-o-Y Growth Comparison by Anatomy, 2026-2036
- Figure 109: Middle East & Africa Market Attractiveness Analysis by Anatomy
- Figure 110: Middle East & Africa Market Value Share and BPS Analysis by End User, 2026 and 2036
- Figure 111: Middle East & Africa Market Y-o-Y Growth Comparison by End User, 2026-2036
- Figure 112: Middle East & Africa Market Attractiveness Analysis by End User
- Figure 113: Middle East & Africa Market Value Share and BPS Analysis by Application, 2026 and 2036
- Figure 114: Middle East & Africa Market Y-o-Y Growth Comparison by Application, 2026-2036
- Figure 115: Middle East & Africa Market Attractiveness Analysis by Application
- Figure 116: Global Market - Tier Structure Analysis
- Figure 117: Global Market - Company Share Analysis
Full Research Suite comprises of:
Market outlook & trends analysis
Interviews & case studies
Strategic recommendations
Vendor profiles & capabilities analysis
5-year forecasts
8 regions and 60+ country-level data splits
Market segment data splits
12 months of continuous data updates
DELIVERED AS:
PDF EXCEL ONLINE
